STRATEGIC GROWTH THROUGH PARTNERSHIP

For CROs

For CROs

The Challenges:

Clinical development continues to become more complex. CROs face increasing pressure to identify experienced sites, accelerate study startup, meet aggressive enrollment timelines, and deliver consistent execution across multiple locations. Managing numerous individual site relationships can slow timelines. Today’s studies require strategic partners that can adapt, scale, and consistently deliver.

Benefits:

Partnering with hyperCORE provides streamlined access to a growing network of exceptional clinical research organizations through one strategic relationship.

  • Unified Access: A single strategic partnership provides streamlined access to multiple high-performing clinical research organizations.
  • Speed: Rapid feasibility responses and site identification through one point of contact, with 48–72-hour feasibility turnaround.
  • Expanded Reach: Scale your studies through broader geographic coverage and access to diverse patient populations across the United States.
  • Therapeutic Expertise: Access experienced investigators and proven research sites spanning a broad range of therapeutic areas and study phases.
  • Scalable Solutions: Whether you need a single site or a multi-site strategy, our network supports Phase I–IV clinical trials with the flexibility to scale alongside your program.
  • Strategic Partnership: Build a long-term relationship with a trusted partner that understands your goals, proactively supports your pipeline, and grows with your development needs.

How We Work:

hyperCORE serves as an extension of your study team. We work closely with CROs to understand protocol requirements, identify the most appropriate research organizations, and coordinate feasibility. While hyperCORE manages the partnership and strategy, our partner organizations execute the study, creating a seamless experience from feasibility through study completion.

Our model is designed to be more than transactional. Whether you need support identifying specialized investigators, expanding into new patient populations, responding to an urgent bid defense request, or strengthening site coverage across a therapeutic area, our team is here to help.

Site Models:

  • Practice-Embedded Research Sites: Integrated directly within physician practices, providing immediate access to established patient populations.
  • Integrated Research Sites: Operating in close collaboration with healthcare systems and specialty practices.
  • Dedicated Research Sites: Independent clinical research centers with experienced research teams.

Therapeutic Areas

Cannabis & Psychedelics
Cardiology
Dermatology Capabilities
Devices / Diagnostics
Endocrinology
Gastroenterology
Hematology
Hepatology
Immunology
Infectious Disease
Men’s Health
Nephrology
Neurology
Oncology
Ophthalmology
Pain Management
Pediatrics
Podiatry
Psychiatry
Pulmonology
Rheumatology
Smoking Cessation
Urology
Vaccine Capabilities
Women’s Health

Phase 1 Details

7 domiciling-capable sites across 5 U.S. states with 18 Principal Investigators

Collectively we have conducted 125 early phase trials — 30 were first-in human trials

60 beds combined

Facilities range from 4,000 to 17,000 SqFt.

Phase 1 Testing / Equipment

hyperCORE by the Numbers

Breakdown by race & ethnicities

Breakdown by race & ethnicities — data
Race / ethnicityPatients
White/Caucasian1,156,000
Black/African American850,000
Hispanic986,000
Asian170,000
Other102,000
First Nation68,000
Native Hawaiian/Pacific Islander68,000

Breakdown by age range

Breakdown by age range — data
Age rangePatients
Pediatric136,000
Adolescent476,000
Adult1,972,000
Senior Adult816,000
ONE STRATEGIC CONNECTION

Connecting CROs with exceptional research networks.

Access experienced sites, investigators, and diverse patient populations through one trusted relationship.
GROWING TOGETHER

Grow without sacrificing independence.

Explore how our partner-owned model supports strategic growth and collaborative opportunities.
LET'S CONNECT

Ready to scale?

Whether you’re looking for a trusted research site partner or opportunities to grow your organization, we’d love to start a conversation.

Start a conversation

Tell us a little about yourself and our business development team will be in touch.